Literature DB >> 25986681

Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.

Yoshihide Asano1.   

Abstract

The lack of animal models recapitulating the three cardinal features of systemic sclerosis (SSc), such as immune activation, vasculopathy, and tissue fibrosis, hinders the understanding of the pathogenesis of this disease. A series of clinical studies has suggested that environmental factors largely contribute to the development of SSc in individuals predisposed by genetic factors. This notion is supported by the establishment of a new murine SSc model which recapitulates three cardinal features of SSc by simultaneous haploinsufficiency of Klf5 and Fli1 genes, both of which are epigenetically suppressed in SSc dermal fibroblasts. In addition to enhanced dermal thickness, Klf5(+/-) and Fli1(+/-) mice resemble dermal fibrosis of SSc at the ultrastructural level. Furthermore, these mice simulate altered vascular structure and B cell activation characteristic of SSc. Further studies on the pathological events in Klf5(+/-) and Fli1(+/-) mice and the roles of KLF5 and Fli1 in various types of cells may provide us with a useful clue to better understand the developmental process of SSc.

Entities:  

Keywords:  Epigenetics; Fli1; KLF5; Systemic sclerosis; Ultrastructure of collagen fibrils

Mesh:

Substances:

Year:  2015        PMID: 25986681     DOI: 10.1007/s00795-015-0107-2

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  43 in total

1.  Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.

Authors:  Christopher P Denton; Bing Zheng; Lowri A Evans; Xu Shi-wen; Voon H Ong; Ivan Fisher; Konstantinos Lazaridis; David J Abraham; Carol M Black; Benoit de Crombrugghe
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

2.  Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Authors:  Carol Feghali-Bostwick; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-07

3.  An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.

Authors:  Jaspreet Pannu; Elizabeth Gore-Hyer; Masayoshi Yamanaka; Edwin A Smith; Semyon Rubinchik; Jian-Yun Dong; Stefania Jablonska; Maria Blaszczyk; Maria Trojanowska
Journal:  Arthritis Rheum       Date:  2004-05

4.  Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.

Authors:  Amélie Servettaz; Claire Goulvestre; Niloufar Kavian; Carole Nicco; Philippe Guilpain; Christiane Chéreau; Vincent Vuiblet; Loïc Guillevin; Luc Mouthon; Bernard Weill; Frédéric Batteux
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

6.  Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation.

Authors:  Yoshihide Asano; Joanna Czuwara; Maria Trojanowska
Journal:  J Biol Chem       Date:  2007-09-19       Impact factor: 5.157

Review 7.  In perspective: murine models of scleroderma.

Authors:  Minghua Wu; John Varga
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

8.  Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta.

Authors:  Yoshihide Asano; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

9.  Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Authors:  Yoshihide Asano; Margaret Markiewicz; Masahide Kubo; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

10.  Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis.

Authors:  Lukasz Stawski; Rong Han; Andreea M Bujor; Maria Trojanowska
Journal:  Arthritis Res Ther       Date:  2012-08-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.